MEDAVAIL HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | 0.00% |
|
0.00% | -100.00% |
| 02-15 | MedAvail Holdings, Inc.(OTCPK:MDVL.Q) dropped from S&P TMI Index | CI |
| 02-15 | MedAvail Holdings, Inc.(OTCPK:MDVL.Q) dropped from S&P TMI Index | CI |
| Sales 2021 | 22.13M 1.77B | Sales 2022 | 43.11M 3.44B | Capitalization | 24M 1.92B |
|---|---|---|---|---|---|
| Net income 2021 | -43M -3.43B | Net income 2022 | -47M -3.75B | EV / Sales 2021 | 1.74 x |
| Net cash position 2021 | 7.44M 594M | Net cash position 2022 | 4.37M 349M | EV / Sales 2022 | 0.46 x |
| P/E ratio 2021 |
-1.04
x | P/E ratio 2022 |
-0.41
x | Employees | 279 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.6% |
More Fundamentals
* Assessed data
More news
Latest transcript on MedAvail Holdings, Inc.
More recommendations
More press releases
| 3 months | -99.99% | ||
| 6 months | -100.00% | ||
| Current year | -100.00% |
1 month
0.00
0.00
Current year
0.004.88
1 year
0.0020.89
3 years
0.00729.50
5 years
0.001 039.50
10 years
0.001 039.50
| Managers | Title | Age | Since |
|---|---|---|---|
Mark Doerr
CEO | Chief Executive Officer | 54 | 09/01/22 |
Ramona Seabaugh
DFI | Director of Finance/CFO | 55 | 19/09/21 |
Will Misloski
SAM | Sales & Marketing | 53 | 31/07/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Laurie McGraw
BRD | Director/Board Member | 60 | 09/01/22 |
Glen D. Stettin
BRD | Director/Board Member | 60 | 17/11/20 |
Robert Faulkner
CHM | Chairman | 61 | 17/11/20 |
MedAvail Holdings, Inc. is a pharmacy technology and services company. The Company is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. It operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.
Calendar
08/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -100.00% | 322 | |
| +12.65% | 82.35B | |
| +20.17% | 71.09B | |
| +20.89% | 37.73B | |
| +15.77% | 32.01B | |
| +9.19% | 27.2B | |
| +3.18% | 26.74B | |
| +3.81% | 26B | |
| +13.27% | 25.5B | |
| +17.14% | 24.76B |
- Stock Market
- Equities
- MYOS Stock
